Robert M. Rydzewski

2.0k total citations · 1 hit paper
22 papers, 1.5k citations indexed

About

Robert M. Rydzewski is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Robert M. Rydzewski has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Robert M. Rydzewski's work include Synthesis and Biological Evaluation (5 papers), HIV/AIDS drug development and treatment (4 papers) and Click Chemistry and Applications (3 papers). Robert M. Rydzewski is often cited by papers focused on Synthesis and Biological Evaluation (5 papers), HIV/AIDS drug development and treatment (4 papers) and Click Chemistry and Applications (3 papers). Robert M. Rydzewski collaborates with scholars based in United States, Poland and Canada. Robert M. Rydzewski's co-authors include Gregory J. Gores, Steven F. Bronk, Ali Canbay, Maria Eugenia Guicciardi, Ariel E. Feldstein, Nathan W. Werneburg, Makiko Taniai, Hajime Higuchi, Hans Maag and Ernest J. Prisbe and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Psychiatry and Hepatology.

In The Last Decade

Robert M. Rydzewski

21 papers receiving 1.5k citations

Hit Papers

Free fatty acids promote hepatic lipotoxicity by stimulat... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert M. Rydzewski United States 14 725 628 243 240 210 22 1.5k
Makoto Asada Japan 21 381 0.5× 1.3k 2.0× 388 1.6× 251 1.0× 311 1.5× 49 2.8k
Makoto Shimazaki Japan 18 766 1.1× 507 0.8× 554 2.3× 489 2.0× 241 1.1× 44 1.8k
Hans Jörg Hacker Germany 22 569 0.8× 516 0.8× 98 0.4× 45 0.2× 505 2.4× 46 1.5k
Shin-Lian Doong Taiwan 15 726 1.0× 591 0.9× 185 0.8× 44 0.2× 384 1.8× 27 1.6k
Yanping Xu China 22 518 0.7× 1.7k 2.6× 73 0.3× 64 0.3× 166 0.8× 46 2.7k
Chang-Fang Chiu Taiwan 26 344 0.5× 873 1.4× 124 0.5× 57 0.2× 202 1.0× 67 1.9k
Christopher Lowe United Kingdom 20 138 0.2× 727 1.2× 370 1.5× 237 1.0× 35 0.2× 45 2.0k
Ciarán N. Cronin United States 22 237 0.3× 967 1.5× 115 0.5× 24 0.1× 198 0.9× 38 1.6k
Dennis S. France United States 21 123 0.2× 1.6k 2.5× 276 1.1× 59 0.2× 271 1.3× 50 2.6k
John I. Germershausen United States 16 373 0.5× 454 0.7× 56 0.2× 57 0.2× 35 0.2× 27 1.1k

Countries citing papers authored by Robert M. Rydzewski

Since Specialization
Citations

This map shows the geographic impact of Robert M. Rydzewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Rydzewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Rydzewski more than expected).

Fields of papers citing papers by Robert M. Rydzewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Rydzewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Rydzewski. The network helps show where Robert M. Rydzewski may publish in the future.

Co-authorship network of co-authors of Robert M. Rydzewski

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Rydzewski. A scholar is included among the top collaborators of Robert M. Rydzewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Rydzewski. Robert M. Rydzewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rydzewski, Robert M.. (2023). The Balkan Route. 1 indexed citations
2.
Rydzewski, Robert M.. (2009). Real world drug discovery: a chemist's guide to biotech and pharmaceutical research. Choice Reviews Online. 46(8). 46–4454. 28 indexed citations
3.
Dang, Qun, Brian S. Brown, Yan Liu, et al.. (2009). Fructose-1,6-bisphosphatase Inhibitors. 1. Purine Phosphonic Acids as Novel AMP Mimics. Journal of Medicinal Chemistry. 52(9). 2880–2898. 48 indexed citations
4.
Dang, Qun, Robert M. Rydzewski, Daniel K. Cashion, & Mark D. Erion. (2008). An unexpected cyclization discovered during the synthesis of 8-substituted purines from a 4,5-diaminopyrimidine. Tetrahedron Letters. 49(13). 2143–2145. 1 indexed citations
5.
Dang, Qun, Yan Liu, Robert M. Rydzewski, et al.. (2007). Bis[(para-methoxy)benzyl] phosphonate prodrugs with improved stability and enhanced cell penetration. Bioorganic & Medicinal Chemistry Letters. 17(12). 3412–3416. 9 indexed citations
6.
Palmer, James T., Robert M. Rydzewski, Rohan Mendonca, et al.. (2006). Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(13). 3434–3439. 17 indexed citations
7.
Rydzewski, Robert M., Leland C. Burrill, Rohan Mendonca, et al.. (2006). Optimization of Subsite Binding to the β5 Subunit of the Human 20S Proteasome Using Vinyl Sulfones and 2-Keto-1,3,4-oxadiazoles:  Syntheses and Cellular Properties of Potent, Selective Proteasome Inhibitors. Journal of Medicinal Chemistry. 49(10). 2953–2968. 35 indexed citations
8.
Feldstein, Ariel E., Nathan W. Werneburg, Ali Canbay, et al.. (2004). Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway. Hepatology. 40(1). 185–194. 655 indexed citations breakdown →
9.
Canbay, Ali, Maria Eugenia Guicciardi, Hajime Higuchi, et al.. (2003). Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. Journal of Clinical Investigation. 112(2). 152–159. 165 indexed citations
10.
Canbay, Ali, Maria Eugenia Guicciardi, Hajime Higuchi, et al.. (2003). Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. Journal of Clinical Investigation. 112(2). 152–159. 162 indexed citations
11.
Cathers, Brian E., et al.. (2002). pH Dependence of inhibitors targeting the occluding loop of cathepsin B. Bioorganic Chemistry. 30(4). 264–275. 18 indexed citations
12.
Rydzewski, Robert M.. (2002). Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitors. Bioorganic & Medicinal Chemistry. 10(10). 3277–3284. 17 indexed citations
13.
Falgueyret, Jean‐Pierre, Renata M. Oballa, Osamu Okamoto, et al.. (2000). Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L. Journal of Medicinal Chemistry. 44(1). 94–104. 106 indexed citations
15.
16.
Maag, Hans, et al.. (1992). Synthesis and anti-HIV activity of 4'-azido- and 4'-methoxynucleosides. Journal of Medicinal Chemistry. 35(8). 1440–1451. 137 indexed citations
17.
MCGEE, D. P. C., et al.. (1988). Synthesis and antiviral evaluation of 6'-substituted aristeromycins: potential mechanism-based inhibitors of S-adenosylhomocysteine hydrolase. Journal of Medicinal Chemistry. 31(9). 1798–1804. 50 indexed citations
18.
Djurić, Stevan W., Masateru Miyano, Michael Clare, & Robert M. Rydzewski. (1987). A stereocontrolled synthesis of a novel prostacyclin analog “allene-carbacyclin”. Application of molecular mechanics calculations to organic synthesis.. Tetrahedron Letters. 28(3). 299–302. 10 indexed citations
19.
20.
Zetin, Mark, Haya R. Rubin, & Robert M. Rydzewski. (1981). Tricyclic antidepressant sample stability and the vacutainer effect. American Journal of Psychiatry. 138(9). 1247–1248. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026